Padmanabh P. Bhatt - 22 Feb 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: Sr. VP of IP, CSO
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol: SUPN
Transactions as of: 22 Feb 2023
Transactions value $: $0
Form type: 4
Filing time: 24 Feb 2023, 16:06:01 UTC
Previous filing: 19 Jan 2023
Next filing: 27 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SUPN	Common Stock	Award	$0	+750	+30.04%	$0.00	3.25K	22 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Restricted Stock Units	Disposed to Issuer	$0	-750	-25%	$0.00	2.25K	22 Feb 2023	Common Stock	750		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes an aggregate of 853 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2	Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3	These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023.